#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haematological malignancy Brain injury Adrenoleukodystrophy Brain abscess Hereditary spastic paraplegia Leukaemia Hyperoxaluria Cholangiosarcoma Oesophageal adenocarcinoma Ovarian cancer stage IV Myelodysplastic syndrome Chronic lymphocytic leukaemia refractory Ewing's sarcoma metastatic Spinal cord injury cervical Human papilloma virus immunisation More trials…

    Learn about Rare Diseases

    Lysosomal storage disorder – Treatment Gaucher’s disease type I Ocular melanoma Pulmonary sarcoidosis – Treatment Hereditary ataxia Richter’s syndrome – Trials in Disease Hereditary optic atrophy – Basic Information Epidermolysis bullosa – Diagnostics Systemic sclerosis pulmonary – Treatment Mucopolysaccharidosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Opium, Standardized Powdered Rbl012.2 Mebendazole Bicalutamide Timbetasin Acetate Casirivimab Ivermectin Human Normal Immunoglobulin ZINC GLUCONATE Salmeterol Xinafoate Ligelizumab Cenobamate Sodium Lactate Canagliflozin Betamethasone Dipropionate Rhh646 Roxithromycin Melphalan Mps-106 Fludrocortisone More therapies…

    Learn about Your Condition

    Monogenic diabetes Cervix carcinoma stage III Arterial tortuosity syndrome Type V hyperlipidaemia Guttate psoriasis Vascular calcification Stargardt's disease Coronary artery occlusion Cardiac failure Knee arthroplasty Yellow fever Osteoporosis postmenopausal Arrhythmia supraventricular Anal fistula Hodgkin's disease refractory More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Adenocarcinoma pancreas

  • Study on Preoperative Treatment with mFOLFIRINOX or Gemcitabine-Paclitaxel for Patients with Borderline Resectable Pancreatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • ANHYDROUS CALCIUM FOLINATE
    • Irinotecan
    • Fluorouracil
    Belgium

  • Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Biliary cancer metastatic
    • Breast cancer recurrent
    • Breast cancer stage IV
    Investigated Drugs:
    • Ds-3939A
    Belgium France Spain

  • Study on 68Ga-FAPI-46 for Imaging in Patients with Non-Metastatic Pancreatic Cancer

    Recruiting

    1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    France

  • Study of immune response and biomarkers in patients with metastatic solid tumors treated with BMS-986340 and nivolumab

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    • Adenocarcinoma pancreas
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Bms-986340
    • Nivolumab
    Italy

  • Efficacy and Safety of SIL204 Combined with Standard Chemotherapy in Patients with Locally Advanced Pancreatic Cancer

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Germany

  • Study of Gemcitabine with Paclitaxel versus Standard Chemotherapy Combination for Patients with Borderline Resectable Pancreatic Cancer Based on Gene Analysis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Gemcitabine
    France
Previous Page
1 2 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!